- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| WORK MEDICAL TECHNOLOGY GROUP Aktie jetzt für 0€ handeln | |||||
| Mo | WORK Medical Technology Group LTD: WORK Medical Collaborates with Novabioplus to Unlock Biological Data Value with AI, Advancing the "BioToken" Assetization Model | 7 | GlobeNewswire (USA) | ||
| 01.05. | WORK Medical Technology Group LTD: WORK Medical Deepens Web3.0 Strategic Layout: Co-authors Asset Tokenization Whitepaper | 1 | GlobeNewswire (USA) | ||
| 15.04. | WORK Medical Technology Group LTD - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 27.02. | WORK Medical Technology Group LTD - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 10.02. | WORK Medical Technology Group LTD - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 30.01. | WORK Medical Technology Group LTD - 20-F, Annual and transition report of foreign private issuers | 1 | SEC Filings | ||
| 30.12.25 | Work Medical Technology Group schließt Aktienzusammenlegung im Verhältnis 100:1 ab | 5 | Investing.com Deutsch | ||
| 30.12.25 | WORK Medical Technology Group LTD - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 29.12.25 | WORK Medical Shares Jump 9% On Exclusive AI Blood Analysis Deal In China | 1 | RTTNews | ||
| 29.12.25 | WORK Medical Signs East China Distribution Deal For AI Blood Analyzer, Stock Up | 1 | RTTNews | ||
| 29.12.25 | Produktionszulassung für KI-Blutanalysegerät beflügelt Aktie von WORK Medical | 2 | Investing.com Deutsch | ||
| 29.12.25 | WORK Medical subsidiary signs exclusive distribution deal for blood analyzer | 1 | Investing.com | ||
| 29.12.25 | WORK Medical schließt exklusiven Vertriebsvertrag für KI-Blutanalysegerät in Ostchina | - | Investing.com Deutsch | ||
| 29.12.25 | WORK Medical Technology Group LTD: WORK Medical Grants East China Exclusive Distribution Rights for AI-Automated Blood Cell Morphology Analyzer, Sets RMB10 Million Sales Target for 2026 | 437 | GlobeNewswire (Europe) | Hangzhou, China, Dec. 29, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) ("WORK Medical", the "Company" or "we"), a supplier of medical devices in China, through its subsidiary... ► Artikel lesen | |
| 29.12.25 | HANGZHOU - WORK Medical subsidiary receives AI blood analyzer approval | 1 | Investing.com | ||
| 29.12.25 | WORK Medical erhält Zulassung für KI-gestütztes Blutanalysegerät | 1 | Investing.com Deutsch | ||
| 29.12.25 | WORK Medical Technology Group LTD Subsidiary Obtains Manufacturing Approval for Its AI-Automated Blood Cell Morphology Analyzer | 247 | GlobeNewswire (Europe) | Hangzhou, China, Dec. 29, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) ("WORK Medical" or the "Company"), a supplier of medical devices in China, through its subsidiary... ► Artikel lesen | |
| 24.12.25 | WORK Medical führt Aktienzusammenlegung im Verhältnis 1:100 durch | 13 | Investing.com Deutsch | ||
| 24.12.25 | WORK Medical to implement 1-for-100 reverse stock split | 3 | Investing.com | ||
| 24.12.25 | WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective December 29, 2025 | 745 | GlobeNewswire (Europe) | Hangzhou, China, Dec. 24, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) ("WORK Medical" or the "Company"), a supplier of medical devices in China, through its subsidiary... ► Artikel lesen |
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 5,722 | -2,69 % | Teladoc Health extends rally to seventh straight session, gaining 22% | ||
| HIMS & HERS HEALTH | 21,380 | -13,65 % | Earnings Preview: Nebius, Hims & Hers, Cisco & Co. Welche Zahlen diese Woche spannend werden! | © Foto: Yuki Iwamura - AP/dpa +++ dpa-Bildfunk +++Diese in den kommenden Tagen (KW20) anstehenden US-Quartalszahlen müssen Anlegerinnen und Anleger kennen: Herausforderungen, Erwartungen und die aktuell... ► Artikel lesen | |
| PLUS THERAPEUTICS | 5,190 | 0,00 % | Plus Therapeutics Inc.: Plus Therapeutics Receives Medicare Enrollment Approval for CNSide Diagnostic | HOUSTON, May 07, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals... ► Artikel lesen | |
| HEALWELL AI | 0,565 | +1,62 % | HEALWELL verzeichnet im 1. Quartal 2026 eine Umsatzsteigerung von 316 % und verbessert die Kundenbindung | - HEALWELL erzielte im ersten Quartal 2026 einen Quartalsumsatz aus fortlaufender Betriebstätigkeit in Höhe von 33,2 Millionen $, was einem Anstieg um 316 % gegenüber dem im
ersten Quartal... ► Artikel lesen | |
| ORGANON | 11,315 | 0,00 % | Organon & Co.: Europäische Kommission erteilt Marktzulassung für POHERDY (Pertuzumab) von Henlius und Organon, das erste in Europa zugelassene Biosimilar zu PERJETA (Pertuzumab) | Shanghai Henlius Biotech, Inc. (2696.HK) und Organon (NYSE: OGN) gaben heute bekannt, dass die Europäische Kommission die Zulassung für POHERDY (Pertuzumab) 420 mg/14 ml Injektion zur intravenösen... ► Artikel lesen | |
| CO-DIAGNOSTICS | 1,720 | -9,47 % | Co-Diagnostics JV secures KSA facility lease deal; CODX rallies 16% premarket | ||
| VERU | 2,270 | +2,71 % | Veru Inc.: Veru to Report Fiscal 2026 Second Quarter Financial Results on May 13th | ||
| CLOVER HEALTH INVESTMENTS | 2,780 | +2,21 % | CLOVER HEALTH INVESTMENTS, CORP. /DE - 10-Q, Quarterly Report | ||
| SENSEONICS | 4,680 | -4,49 % | H.C. Wainwright cuts Senseonics stock price target on dilution | ||
| ELEKTA | 5,190 | -1,33 % | Dividendenbekanntmachungen (05.03.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AMERICAN ASSETS TRUST INC US0240131047 0,34 USD 0,2922 EUR ARMSTRONG WORLD INDUSTRIES INC US04247X1028 0,339 USD 0,2914 EUR ASSOCIATED... ► Artikel lesen | |
| IMUNON | 2,380 | +3,48 % | Imunon Reports Q1 2026 Results: Full Earnings Call Transcript | ||
| PERSPECTIVE THERAPEUTICS | 3,218 | -2,37 % | Perspective Therapeutics, Inc.: Perspective Therapeutics Provides Recent Business Highlights and Reports 1Q 2026 Results | Differentiated ²¹²Pb radiopharmaceutical platform designed to optimize tumor killing, safety, patient convenience and supply scalabilityThree clinical-stage oncology programs advancing across neuroendocrine... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 28,730 | +8,62 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| AXE COMPUTE | 5,750 | +2,68 % | Morning Market Movers: Axe Compute, Inhibrx Biosciences, Huachen AI Parking Management Technology, 1-800-FLOWERS.COM See Big Swings | OTTAWA (dpa-AFX) - At 9:00 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| NIAGEN BIOSCIENCE | 3,380 | 0,00 % | Niagen Bioscience stock price target lowered to $11 by H.C. Wainwright |
WORK MEDICAL TECHNOLOGY GROUP LTD gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von +3,410 (+86,99 %) liegt der Kurs bei 7,330 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu WORK MEDICAL TECHNOLOGY GROUP LTD finden Sie auf Wallstreet Online.